GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
NCT04036526: A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Unknown status
1/2
50
RoW
Vaccine GamLPV, live intranasal Bordetella pertussis vaccine, Placebo
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Whooping Cough
05/20
09/20

Download Options